“ Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents ” (2014) Archives of Clinical Psychiatry, 41(2), pp. 34–39. doi:10.1590/0101-60830000000007.